why choose us

First received: November 27, 2023

Clinical Trial: ACP-204 in Adults With Alzheimer's Disease Psychosis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Alzheimer's Disease Psychosis

Study Type: INTERVENTIONAL


Official Title: A Master Protocol for Three Independent, Seamlessly Enrolling, Double-blind, Placebo-controlled Efficacy and Safety Studies of ACP-204 in Adults With Alzheimer's Disease Psychosis

Brief Summary: This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies in patients with ADPSubstudy 1 (Phase 2) will evaluate efficacy and dose response of ACP-204 30 and 60 mg vs placebo.This substudy will be initiated first.Substudies 2A and 2B (both: Phase 3) will be confirmatory studies of either both doses (ACP-204 30 and 60 mg, respectively) or a single dose from Part 1 vs placebo.Substudies 2A and 2B will be performed…

Read more